What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Surgery
- Osteoporosis
Jonathan D. Adachi mostly deals with Osteoporosis, Internal medicine, Surgery, Bone density and Physical therapy.
His Osteoporosis research is multidisciplinary, incorporating perspectives in Placebo, Randomized controlled trial and Confidence interval.
In his research, Parathyroid hormone is intimately related to Endocrinology, which falls under the overarching field of Internal medicine.
His Surgery research includes elements of Risedronic acid, Fracture risk, Femoral neck and Risk factor.
His Bone density research also works with subjects such as
- Menopause which connect with Adverse effect,
- Intensive care medicine which intersects with area such as MEDLINE and Bone Density Conservation Agents.
His study in Physical therapy is interdisciplinary in nature, drawing from both Hip fracture, Cohort study, Orthopedic surgery, Quality of life and Pediatrics.
His most cited work include:
- Zoledronic acid and clinical fractures and mortality after hip fracture (1411 citations)
- Canadian normative data for the SF-36 health survey (609 citations)
- Intermittent etidronate therapy to prevent corticosteroid-induced osteoporosis. (572 citations)
What are the main themes of his work throughout his whole career to date?
His primary scientific interests are in Osteoporosis, Internal medicine, Physical therapy, Surgery and Bone density.
His studies deal with areas such as Orthopedic surgery and Placebo as well as Osteoporosis.
The study of Internal medicine is intertwined with the study of Endocrinology in a number of ways.
He works mostly in the field of Physical therapy, limiting it down to concerns involving Randomized controlled trial and, occasionally, Meta-analysis, MEDLINE and Adverse effect.
As part of one scientific family, Jonathan D. Adachi deals mainly with the area of Surgery, narrowing it down to issues related to the Confidence interval, and often Odds ratio.
His Bone density research is multidisciplinary, incorporating elements of Relative risk, Prospective cohort study and Pediatrics.
He most often published in these fields:
- Osteoporosis (65.36%)
- Internal medicine (37.68%)
- Physical therapy (33.62%)
What were the highlights of his more recent work (between 2016-2021)?
- Osteoporosis (65.36%)
- Internal medicine (37.68%)
- Physical therapy (33.62%)
In recent papers he was focusing on the following fields of study:
Jonathan D. Adachi spends much of his time researching Osteoporosis, Internal medicine, Physical therapy, Randomized controlled trial and Hip fracture.
His Osteoporosis research integrates issues from Orthopedic surgery, Incidence and Confidence interval.
His study brings together the fields of Placebo and Internal medicine.
His work in Physical therapy addresses issues such as Intervention, which are connected to fields such as Home exercise.
His biological study deals with issues like Psychological intervention, which deal with fields such as MEDLINE.
His work is dedicated to discovering how Hip fracture, Cohort are connected with Osteoporotic fracture and other disciplines.
Between 2016 and 2021, his most popular works were:
- Cortical and trabecular bone microarchitecture as an independent predictor of incident fracture risk in older women and men in the Bone Microarchitecture International Consortium (BoMIC): a prospective study (84 citations)
- Denosumab versus risedronate in glucocorticoid-induced osteoporosis: a multicentre, randomised, double-blind, active-controlled, double-dummy, non-inferiority study (80 citations)
- Biologic therapies and bone loss in rheumatoid arthritis. (64 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Surgery
- Disease
His scientific interests lie mostly in Osteoporosis, Internal medicine, MEDLINE, Physical therapy and Family medicine.
His Osteoporosis research is multidisciplinary, relying on both Zoledronic acid and Confidence interval.
His biological study spans a wide range of topics, including Randomized controlled trial, Gerontology and Scale.
His research investigates the connection between Family medicine and topics such as Systematic review that intersect with problems in Primary outcome and Observational study.
His research in Hip fracture intersects with topics in Body mass index and Cohort.
In his study, Incidence is inextricably linked to Surgery, which falls within the broad field of Glucocorticoid.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
